Nearly two dozen states sued the Trump administration Tuesday over its rollback of ownership reporting requirements for corporate entities, arguing the move constitutes an illegal, unilateral repeal of an anti-financial crime law that Congress enacted.
Nearly two dozen states sued the Trump administration Tuesday over its rollback of ownership reporting requirements for corporate entities, arguing the move constitutes an illegal, unilateral repeal of an anti-financial crime law that Congress enacted.
An ex-worker hit M&T Bank with a proposed class action in New Jersey federal court, alleging that an underperforming investment fund in the bank's employee 401(k) plan cost workers tens of millions in future savings, breaching fiduciary duties under federal benefits law.
FCA US LLC has agreed to pay up to $5 million to resolve proposed class claims alleging it sold Jeep Wrangler plug-in hybrid vehicles with a defect that renders electric driving unavailable, while class counsel plans to seek an additional $2 million in fees, costs, expenses and incentive awards.
The New Jersey Department of Environmental Protection backed various DuPont entities' bid to toss the remaining claims in a municipality's $1 billion lawsuit over forever chemical contamination stemming from a longtime DuPont facility, arguing that a landmark settlement the state reached earlier this year bars the claims.
An investor is suing UP Fintech Holding Ltd. in New Jersey federal court, alleging the fintech company and its top brass misrepresented and understated its legal and regulatory risk "as a result of continued illegal activity in China."
The New Jersey Administrative Office of the Courts urged a state court to toss a former municipal judge's retaliation claims, arguing that the office is not the judge's employer and that his suit lacks facts to support the claims.
A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.
A New Jersey federal judge has upheld the U.S. Patent and Trademark Office's refusal to extend the life of a pair of patents on a cancer drug, rejecting a challenge from the patent owner that claimed the loss of exclusivity would cost it more than $1 billion.
Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.
While the Second Circuit’s recent U.S. v. Alisigwe decision confirms border agents' broad authority to conduct routine manual cellphone searches at ports of entry, significant questions remain about more wide-ranging forensic searches at the border, say attorneys at Baker Botts.
The U.S. Department of Justice late Tuesday acknowledged that it confused key statutory terms related to jury instructions at famed appellate advocate Tom Goldstein's criminal trial, while also insisting "the government's mistake here was understandable" and shouldn't upend a jury's guilty verdict.
The widow of a Miami real estate investor is suing a former president of the Florida Bar for malpractice, claiming his botched representation left her without a claim to her late husband's $350 million estate.
A high-stakes case that will determine whether the U.S. government should face patent infringement claims over Moderna's COVID-19 vaccines and Labcorp's appeal of a nine-figure patent verdict against it are among the arguments the Federal Circuit will hear in November.
The Fourth Circuit on Tuesday affirmed a district court determination striking down as unconstitutional West Virginia's law restricting the publication of the home addresses and phone numbers of law enforcement and judicial officials, saying the district court applied "well-established" First Amendment principles.
